Association of M-Type Phospholipase A2 Receptor Deposition in Kidney Tissue with Treatment Outcomes in Patients with Idiopathic Membranous Nephropathy

被引:1
作者
Xie, Ning-Qiu [1 ]
Zhang, Yu-Lin [2 ]
Zheng, Zi-Li [1 ]
Zheng, Quan-Lin [1 ]
Chen, Ruo-Ji [1 ,3 ]
机构
[1] Jinjiang Municipal Hosp, Dept Nephrol, Jinjiang 362200, Fujian, Peoples R China
[2] Jinjiang Municipal Hosp, Dept Pediat, Jinjiang 362200, Fujian, Peoples R China
[3] Jinjiang Municipal Hosp, Dept Nephrol, Baolong Int Community, Changxing Rd,288 Qingyang St, Jinjiang City 362200, Fujian, Peoples R China
关键词
anti-M-type phospholipase A2 receptor; idiopathic membranous nephropathy; IgG4; FEATURES;
D O I
10.2147/JIR.S427045
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: The purpose of this study was to investigate the correlation between the deposition of M-type phospholipase A2 receptor (PLA2R) in the kidney tissues of patients with idiopathic membranous nephropathy (IMN). Method: We enrolled a total of 61 patients diagnosed with IMN in the past 8 years who were admitted at the Jinjiang Municipal Hospital and the 2nd Affiliated Hospital of Fujian Medical University. PLA2R immunofluorescence was used to stain kidney tissues, and all patients were treated with steroid combined with immunosuppressive agents or conservative regimens. The duration of followup was more than 48 weeks. Based on the deposition of PLA2R in kidney tissues, we divided the patients into the PLA2R Positive group and the PLA2R Negative group. Further, patients with PLA2R-positive kidney tissues were divided into "1+", "2+", and "3+" groups based on the extent of their PLA2R deposition, and we compared the therapeutic outcomes of the various groups. Results: At week 12 of follow-up, the partial remission rate of kidney tissues in the PLA2R Negative group was significantly higher than that in the Positive group (P = 0.004). Among the various deposition groups with PLA2R-positive kidney tissues, the complete remission rate of the "2+" group was higher than that of the "3+" group at weeks 24, 36, and 48 of follow-up (P < 0.05). In IMN patients treated with a combination regimen of steroid and tacrolimus, the complete remission rate in kidney tissues of the PLA2R Negative group was higher than that of the Positive group at weeks 24 and 48 of follow-up (P < 0.05). Conclusion: The overall effective rate of treatment in kidney tissues of PLA2R-negative patients was higher than that in the kidney tissues of PLA2R-positive patients. The varied levels of PLA2R deposition in kidney tissues were related to the treatment outcomes of IMN, and those with lower PLA2R deposition levels had better outcomes.
引用
收藏
页码:6319 / 6328
页数:10
相关论文
共 15 条
[1]   M-Type Phospholipase A(sub 2) Receptor as Target Antigen in Idiopathic Membranous Nephropathy. [J].
Beck, Laurence H., Jr. ;
Bonegio, Ramon G. B. ;
Lambeau, Gerard ;
Beck, David M. ;
Powell, David W. ;
Cummins, Timothy D. ;
Klein, Jon B. ;
Salant, David J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (01) :11-21
[2]   Detection of PLA2R Autoantibodies before the Diagnosis of Membranous Nephropathy [J].
Burbelo, Peter D. ;
Joshi, Megha ;
Chaturvedi, Adrija ;
Little, Dustin J. ;
Thurlow, John S. ;
Waldman, Meryl ;
Olson, Stephen W. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (01) :208-217
[3]   Primary Membranous Nephropathy [J].
Couser, William G. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (06) :983-997
[4]  
Cui J, 2015, J CLIN EXP PATHOL, V31, P333
[5]  
Hou X, 2020, J PRACT MED, V37, P901
[6]  
Li JN, 2015, DIAGNOSIS IDIOPATHIC
[7]   Detection and clinical significance of glomerular M-type phospholipase A2 receptor in patients with idiopathic membranous nephropathy [J].
Liu, H. ;
Luo, W. ;
Gong, S. ;
Ding, X. .
INTERNAL MEDICINE JOURNAL, 2016, 46 (11) :1318-1322
[8]   Membranous nephropathy [J].
Ronco, Pierre ;
Beck, Laurence ;
Debiec, Hanna ;
Fervenza, Fernando C. ;
Hou, Fan Fan ;
Jha, Vivekanand ;
Sethi, Sanjeev ;
Tong, Allison ;
Vivarelli, Marina ;
Wetzels, Jack .
NATURE REVIEWS DISEASE PRIMERS, 2021, 7 (01)
[9]   Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases [J].
Rovin, Brad H. ;
Adler, Sharon G. ;
Barratt, Jonathan ;
Bridoux, Frank ;
Burdge, Kelly A. ;
Chan, Tak Mao ;
Cook, H. Terence ;
Fervenza, Fernando C. ;
Gibson, Keisha L. ;
Glassock, Richard J. ;
Jayne, David R. W. ;
Jha, Vivekanand ;
Liew, Adrian ;
Liu, Zhi-Hong ;
Mejia-Vilet, Juan M. ;
Nester, Carla M. ;
Radhakrishnan, Jai ;
Rave, Elizabeth M. ;
Reich, Heather N. ;
Ronco, Pierre ;
Sanders, Jan-Stephan F. ;
Sethi, Sanjeev ;
Suzuki, Yusuke ;
Tang, Sydney C. W. ;
Tesar, Vladimir ;
Vivarelli, Marina ;
Wetzels, Jack F. M. ;
Lytvyn, Lyubov ;
Craig, Jonathan C. ;
Tunnicliffe, David J. ;
Howell, Martin ;
Tonelli, Marcello A. ;
Cheung, Michael ;
Earley, Amy ;
Floege, Jurgen .
KIDNEY INTERNATIONAL, 2021, 100 (04) :753-779
[10]   Membranous nephropathy: diagnosis, treatment, and monitoring in the post-PLA2R era [J].
Safar-Boueri, Luisa ;
Piya, Albina ;
Beck, Laurence H., Jr. ;
Ayalon, Rivka .
PEDIATRIC NEPHROLOGY, 2021, 36 (01) :19-30